{"id":"https://openalex.org/W2016154588","doi":"https://doi.org/10.1177/0269881107082108","title":"Pharmacodynamic and pharmacokinetic effects of MK-0343, a GABA A \u03b1 2,3 subtype selective agonist, compared to lorazepam and placebo in healthy male volunteers","display_name":"Pharmacodynamic and pharmacokinetic effects of MK-0343, a GABA A \u03b1 2,3 subtype selective agonist, compared to lorazepam and placebo in healthy male volunteers","alternate_titles":[],"publication_year":2007,"publication_date":"2007-08-22","ids":{"openalex":"https://openalex.org/W2016154588","doi":"https://doi.org/10.1177/0269881107082108","mag":"2016154588","pmid":"https://pubmed.ncbi.nlm.nih.gov/18187530"},"language":"en","primary_location":{"id":"doi:10.1177/0269881107082108","doi":"https://doi.org/10.1177/0269881107082108","is_oa":false,"landing_page_url":"https://doi.org/10.1177/0269881107082108","pdf_url":null,"source":{"id":"https://openalex.org/S136368880","display_name":"Journal of Psychopharmacology","issn_l":"0269-8811","issn":["0269-8811","1461-7285"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Psychopharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2016154588"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113654861","display_name":"Sanne Lysbet de Haas","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210133171","display_name":"Centre for Human Drug Research","ror":"https://ror.org/044hshx49","country_code":"NL","type":"facility","lineage":["https://openalex.org/I4210133171"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"S.L. de Haas","raw_affiliation_strings":["Centre for Human Drug Research, Leiden, The Netherlands,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Human Drug Research, Leiden, The Netherlands,","institution_ids":["https://openalex.org/I4210133171"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004955412","display_name":"Saco J. de Visser","orcid":"https://orcid.org/0000-0003-3649-5714","observed_orcids":["https://orcid.org/0000-0003-3649-5714"]},"institutions":[{"id":"https://openalex.org/I4210133171","display_name":"Centre for Human Drug Research","ror":"https://ror.org/044hshx49","country_code":"NL","type":"facility","lineage":["https://openalex.org/I4210133171"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"S.J. de Visser","raw_affiliation_strings":["Centre for Human Drug Research, Leiden, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Human Drug Research, Leiden, The Netherlands","institution_ids":["https://openalex.org/I4210133171"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111956979","display_name":"J. P. Van Der Post","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210133171","display_name":"Centre for Human Drug Research","ror":"https://ror.org/044hshx49","country_code":"NL","type":"facility","lineage":["https://openalex.org/I4210133171"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"J.P. van der Post","raw_affiliation_strings":["Centre for Human Drug Research, Leiden, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Human Drug Research, Leiden, The Netherlands","institution_ids":["https://openalex.org/I4210133171"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076556524","display_name":"Rik C. Schoemaker","orcid":"https://orcid.org/0000-0002-7538-3005","observed_orcids":["https://orcid.org/0000-0002-7538-3005"]},"institutions":[{"id":"https://openalex.org/I4210133171","display_name":"Centre for Human Drug Research","ror":"https://ror.org/044hshx49","country_code":"NL","type":"facility","lineage":["https://openalex.org/I4210133171"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"R.C. Schoemaker","raw_affiliation_strings":["r Centre for Human Drug Research, Leiden, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"r Centre for Human Drug Research, Leiden, The Netherlands","institution_ids":["https://openalex.org/I4210133171"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073601901","display_name":"Kristien Van Dyck","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210121359","display_name":"MSD (Belgium)","ror":"https://ror.org/02j4p4h77","country_code":"BE","type":"company","lineage":["https://openalex.org/I1285764155","https://openalex.org/I4210121359"]}],"countries":["BE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"K. van Dyck","raw_affiliation_strings":["MSD (Europe) Inc., Brussels, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MSD (Europe) Inc., Brussels, Belgium","institution_ids":["https://openalex.org/I4210121359"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108373265","display_name":"M. Gail Murphy","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I192545095","display_name":"United States Military Academy","ror":"https://ror.org/01jepya76","country_code":"US","type":"education","lineage":["https://openalex.org/I1304082316","https://openalex.org/I1330347796","https://openalex.org/I192545095","https://openalex.org/I4210088792"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M.G. Murphy","raw_affiliation_strings":["MRL, Upper Gwynedd/West Point, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MRL, Upper Gwynedd/West Point, PA, USA","institution_ids":["https://openalex.org/I192545095"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110822813","display_name":"M. De Smet","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210121359","display_name":"MSD (Belgium)","ror":"https://ror.org/02j4p4h77","country_code":"BE","type":"company","lineage":["https://openalex.org/I1285764155","https://openalex.org/I4210121359"]}],"countries":["BE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M. de Smet","raw_affiliation_strings":["MSD (Europe) Inc., Brussels, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MSD (Europe) Inc., Brussels, Belgium","institution_ids":["https://openalex.org/I4210121359"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030616432","display_name":"Laura K. Vessey","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I192545095","display_name":"United States Military Academy","ror":"https://ror.org/01jepya76","country_code":"US","type":"education","lineage":["https://openalex.org/I1304082316","https://openalex.org/I1330347796","https://openalex.org/I192545095","https://openalex.org/I4210088792"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"L.K. Vessey","raw_affiliation_strings":["MRL, Upper Gwynedd/West Point, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MRL, Upper Gwynedd/West Point, PA, USA","institution_ids":["https://openalex.org/I192545095"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034284289","display_name":"Renu Ramakrishnan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I192545095","display_name":"United States Military Academy","ror":"https://ror.org/01jepya76","country_code":"US","type":"education","lineage":["https://openalex.org/I1304082316","https://openalex.org/I1330347796","https://openalex.org/I192545095","https://openalex.org/I4210088792"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"R. Ramakrishnan","raw_affiliation_strings":["MRL, Upper Gwynedd/West Point, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MRL, Upper Gwynedd/West Point, PA, USA","institution_ids":["https://openalex.org/I192545095"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101924790","display_name":"Ling Xue","orcid":"https://orcid.org/0000-0003-4348-6496","observed_orcids":["https://orcid.org/0000-0003-4348-6496"]},"institutions":[{"id":"https://openalex.org/I192545095","display_name":"United States Military Academy","ror":"https://ror.org/01jepya76","country_code":"US","type":"education","lineage":["https://openalex.org/I1304082316","https://openalex.org/I1330347796","https://openalex.org/I192545095","https://openalex.org/I4210088792"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"L. Xue","raw_affiliation_strings":["MRL, Upper Gwynedd/West Point, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MRL, Upper Gwynedd/West Point, PA, USA","institution_ids":["https://openalex.org/I192545095"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047227576","display_name":"Adam F. Cohen","orcid":"https://orcid.org/0000-0001-7452-6222","observed_orcids":["https://orcid.org/0000-0001-7452-6222","https://orcid.org/0009-0003-6971-7392"]},"institutions":[{"id":"https://openalex.org/I4210133171","display_name":"Centre for Human Drug Research","ror":"https://ror.org/044hshx49","country_code":"NL","type":"facility","lineage":["https://openalex.org/I4210133171"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"A.F. Cohen","raw_affiliation_strings":["Centre for Human Drug Research, Leiden, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Human Drug Research, Leiden, The Netherlands","institution_ids":["https://openalex.org/I4210133171"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5085437430","display_name":"Joop van Gerven","orcid":"https://orcid.org/0000-0002-1444-7415","observed_orcids":["https://orcid.org/0000-0002-1444-7415"]},"institutions":[{"id":"https://openalex.org/I4210133171","display_name":"Centre for Human Drug Research","ror":"https://ror.org/044hshx49","country_code":"NL","type":"facility","lineage":["https://openalex.org/I4210133171"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"J.M.A. van Gerven","raw_affiliation_strings":["Centre for Human Drug Research, Leiden, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Human Drug Research, Leiden, The Netherlands","institution_ids":["https://openalex.org/I4210133171"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4400,"currency":"USD","value_usd":4400},"apc_paid":null,"fwci":4.4764,"has_fulltext":false,"cited_by_count":109,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.96004909,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"22","issue":"1","first_page":"24","last_page":"32"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.8877000212669373,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.8877000212669373,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10853","display_name":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","score":0.02329999953508377,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10436","display_name":"Anesthesia and Sedative Agents","score":0.019999999552965164,"subfield":{"id":"https://openalex.org/subfields/2703","display_name":"Anesthesiology and Pain Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lorazepam","display_name":"lorazepam","score":0.9160000085830688},{"id":"https://openalex.org/keywords/anxiolytics","display_name":"anxiolytics","score":0.6159999966621399},{"id":"https://openalex.org/keywords/saccades","display_name":"saccades","score":0.8679999709129333},{"id":"https://openalex.org/keywords/alertness","display_name":"alertness","score":0.8220000267028809},{"id":"https://openalex.org/keywords/postural-stability","display_name":"postural stability","score":0.9679999947547913},{"id":"https://openalex.org/keywords/memory-impairment","display_name":"memory impairment","score":0.7680000066757202},{"id":"https://openalex.org/keywords/sedation","display_name":"sedation","score":0.6880000233650208},{"id":"https://openalex.org/keywords/dose-comparison","display_name":"dose comparison","score":0.5540000200271606},{"id":"https://openalex.org/keywords/anxiety-disorders","display_name":"anxiety disorders","score":0.5690000057220459}],"concepts":[{"id":"https://openalex.org/C2779706987","wikidata":"https://www.wikidata.org/wiki/Q408265","display_name":"Lorazepam","level":2,"score":0.7758442163467407},{"id":"https://openalex.org/C2777765862","wikidata":"https://www.wikidata.org/wiki/Q62903","display_name":"Anxiolytic","level":3,"score":0.6570600271224976},{"id":"https://openalex.org/C200678441","wikidata":"https://www.wikidata.org/wiki/Q1423044","display_name":"Alertness","level":2,"score":0.6058714389801025},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.5890927314758301},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.5136498808860779},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.4605490267276764},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.4420274496078491},{"id":"https://openalex.org/C11054436","wikidata":"https://www.wikidata.org/wiki/Q7396580","display_name":"Saccadic masking","level":3,"score":0.43942150473594666},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3937423825263977},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.3854566812515259},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.33755895495414734},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.33245983719825745},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.28349849581718445},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.2663874626159668},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.21632826328277588},{"id":"https://openalex.org/C153050134","wikidata":"https://www.wikidata.org/wiki/Q760256","display_name":"Eye movement","level":2,"score":0.198691725730896},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.18162524700164795},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.11961007118225098},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003071","descriptor_name":"Cognition","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008140","descriptor_name":"Lorazepam","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010147","descriptor_name":"Pain Measurement","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011724","descriptor_name":"Pyridazines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D012438","descriptor_name":"Saccades","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D014151","descriptor_name":"Anti-Anxiety Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D014151","descriptor_name":"Anti-Anxiety Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D018592","descriptor_name":"Cross-Over Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058785","descriptor_name":"GABA-A Receptor Agonists","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1177/0269881107082108","doi":"https://doi.org/10.1177/0269881107082108","is_oa":false,"landing_page_url":"https://doi.org/10.1177/0269881107082108","pdf_url":null,"source":{"id":"https://openalex.org/S136368880","display_name":"Journal of Psychopharmacology","issn_l":"0269-8811","issn":["0269-8811","1461-7285"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Psychopharmacology","raw_type":"journal-article"},{"id":"pmid:18187530","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18187530","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of psychopharmacology (Oxford, England)","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8371999859809875}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320332932","display_name":"Merck Sharp and Dohme","ror":"https://ror.org/004nn4n27"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":68,"referenced_works":["https://openalex.org/W48332013","https://openalex.org/W166264177","https://openalex.org/W173663573","https://openalex.org/W1509193836","https://openalex.org/W1593892605","https://openalex.org/W1596886943","https://openalex.org/W1964372510","https://openalex.org/W1971227264","https://openalex.org/W1973666864","https://openalex.org/W1973936195","https://openalex.org/W1977554432","https://openalex.org/W1986475474","https://openalex.org/W1987341925","https://openalex.org/W1990477196","https://openalex.org/W1990524815","https://openalex.org/W2001463369","https://openalex.org/W2001619275","https://openalex.org/W2013969167","https://openalex.org/W2016940189","https://openalex.org/W2023256667","https://openalex.org/W2023274582","https://openalex.org/W2024817440","https://openalex.org/W2025429574","https://openalex.org/W2033072775","https://openalex.org/W2038477005","https://openalex.org/W2040995746","https://openalex.org/W2042578688","https://openalex.org/W2046047992","https://openalex.org/W2056111477","https://openalex.org/W2056897135","https://openalex.org/W2067237230","https://openalex.org/W2071194186","https://openalex.org/W2074093675","https://openalex.org/W2076425099","https://openalex.org/W2079902803","https://openalex.org/W2081157905","https://openalex.org/W2082354081","https://openalex.org/W2082520951","https://openalex.org/W2083623577","https://openalex.org/W2084874842","https://openalex.org/W2089441306","https://openalex.org/W2090116461","https://openalex.org/W2092519884","https://openalex.org/W2096266931","https://openalex.org/W2099219820","https://openalex.org/W2100216728","https://openalex.org/W2109392677","https://openalex.org/W2120990984","https://openalex.org/W2121060688","https://openalex.org/W2121237571","https://openalex.org/W2129874579","https://openalex.org/W2131375845","https://openalex.org/W2136798511","https://openalex.org/W2140814738","https://openalex.org/W2146125469","https://openalex.org/W2149918533","https://openalex.org/W2151414518","https://openalex.org/W2157050914","https://openalex.org/W2165223719","https://openalex.org/W2203342607","https://openalex.org/W2406214200","https://openalex.org/W2407185944","https://openalex.org/W2418722848","https://openalex.org/W3015493105","https://openalex.org/W3023841804","https://openalex.org/W4246109793","https://openalex.org/W4318746042","https://openalex.org/W4406060998"],"related_works":["https://openalex.org/W7096399652","https://openalex.org/W4246109793","https://openalex.org/W2050546106","https://openalex.org/W41628817","https://openalex.org/W1967722500","https://openalex.org/W2016940189","https://openalex.org/W2076472126","https://openalex.org/W2008215214","https://openalex.org/W2542668511"],"abstract_inverted_index":{"The":[0,195],"use":[1],"of":[2,14,27,38,73,92,108,198,215,245],"non-selective":[3,110],"gamma-aminobutyric":[4],"acid":[5],"(GABA)":[6],"enhancers,":[7],"such":[8],"as":[9,154,191],"benzodiazepines":[10],"in":[11,98,237],"the":[12,39,62,74,90,109,205,212],"treatment":[13],"anxiety":[15,238],"disorders":[16],"is":[17,79,202,247],"still":[18],"widespread":[19],"but":[20],"hampered":[21],"by":[22,116,156],"unfavourable":[23],"side":[24],"effects.":[25,47],"some":[26],"these":[28],"may":[29],"be":[30,52],"associated":[31],"with":[32,152,250],"binding":[33],"properties":[34],"to":[35,51,88,100,187],"certain":[36],"subtypes":[37,72],"GABA(A)":[40,75],"receptor":[41],"that":[42],"are":[43],"unnecessary":[44],"for":[45],"therapeutic":[46],"MK-0343":[48,93,147,180,192,199,246],"was":[49,150,224],"designed":[50],"a":[53,80,188,251],"less":[54,219],"sedating":[55],"anxiolytic,":[56],"based":[57],"on":[58,173,221,228],"reduced":[59],"efficacy":[60,67],"at":[61,68],"alpha1":[63],"subtype":[64],"and":[65,70,95,102,125,139,141,145,164,175,230],"significant":[66],"alpha2":[69],"alpha3":[71],"receptor.":[76],"This":[77],"paper":[78],"double-blind,":[81],"four-way":[82],"cross-over":[83],"(n":[84],"=":[85],"12)":[86],"study":[87],"investigate":[89],"effects":[91,172,227],"(0.25":[94],"0.75":[96,148,193,200],"mg)":[97,107],"comparison":[99],"placebo":[101],"an":[103],"anxiolytic":[104],"dose":[105,244],"(2":[106],"agonist":[111,207],"lorazepam.":[112],"Effects":[113],"were":[114,178,233],"measured":[115],"eye":[117],"movements,":[118],"body":[119],"sway,":[120],"Visual":[121],"Analogue":[122],"scales":[123],"(VAS)":[124],"memory":[126,140,174,229],"tests.":[127],"Lorazepam":[128],"impaired":[129],"saccadic":[130,143,160],"peak":[131],"velocity":[132],"(SPV),":[133],"VAs":[134],"alertness":[135,166,223],"scores,":[136],"postural":[137,176,185,231],"stability":[138,177,186,232],"increased":[142],"latency":[144,161],"inaccuracy.":[146],"mg":[149,182,201],"equipotent":[151],"lorazepam":[153],"indicated":[155],"SPV":[157],"(-42.4":[158],"deg/s),":[159],"(0.02":[162],"s)":[163],"VAS":[165,222],"scores":[167],"(1.50":[168],"ln":[169],"mm),":[170],"while":[171],"smaller.":[179],"0.25":[181],"only":[183],"affected":[184],"similar":[189],"extent":[190],"mg.":[194],"effect":[196,220],"profile":[197],"different":[203,252],"from":[204],"full":[206],"lorazepam,":[208],"which":[209],"could":[210],"reflect":[211],"selective":[213],"actions":[214],"this":[216,243],"compound.":[217],"Although":[218],"expected,":[225],"diminished":[226],"present.":[234],"Clinical":[235],"studies":[236],"patients":[239],"should":[240],"show":[241],"whether":[242],"therapeutically":[248],"effective":[249],"side-effect":[253],"profile.":[254]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2016154588","counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":5},{"year":2012,"cited_by_count":8}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
